PT - JOURNAL ARTICLE AU - Chatzimanolakis, Michail AU - Weber, Pascal AU - Arampatzis, George AU - Wälchli, Daniel AU - Kičić, Ivica AU - Karnakov, Petr AU - Papadimitriou, Costas AU - Koumoutsakos, Petros TI - Optimal Testing Strategy for the Identification of COVID-19 Infections AID - 10.1101/2020.07.20.20157818 DP - 2020 Jan 01 TA - medRxiv PG - 2020.07.20.20157818 4099 - http://medrxiv.org/content/early/2020/07/27/2020.07.20.20157818.short 4100 - http://medrxiv.org/content/early/2020/07/27/2020.07.20.20157818.full AB - The systematic identification of infectious, yet unreported, individuals is critical for the containment of the COVID-19 pandemic. We present a strategy for identifying the location, timing and extent of testing that maximizes information gain for such infections. The optimal testing strategy relies on Bayesian experimental design and forecasting epidemic models that account for time dependent interventions. It is applicable at the onset and spreading of the epidemic and can forewarn for a possible recurrence of the disease after relaxation of interventions. We examine its application in Switzerland and show that it can provide timely and systematic guidance for the effective identification of infectious individuals with finite testing resources. The methodology and the open source code are readily adaptable to countries around the world.We present a strategy for the optimal allocation of testing resources in order to detect COVID-19 infections in a country’s population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge funding by ETH Zurich and computing resources by the Swiss Supercomputing center (CSCS).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:It's a computational study/theoretical work with no risk involved for anyone.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available in the manuscript or the Supplementary Materials.